Two TLR4 agonists, LPS and Spirulina complex polysaccharide, have demonstrated efficacy in mice with subcutaneous implantation of DBT and RSV-M gliomas, respectively (Chicoine et al., 2007; Kawanishi et al., 2013). Here, TLR4 is linked to glioma.